Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The core-binding factor leukemias: lessons learned from murine models.

James R Downing1

  • 1Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. jim.downing@stjude.org

Current Opinion in Genetics & Development
|February 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving survival and reducing suffering for children with NCDs.

Lancet (London, England)·2025
Same author

The Global Platform for Access to Childhood Cancer Medicines: addressing inequities in childhood cancer care.

The Lancet. Oncology·2025
Same author

The genomic landscape of pediatric acute lymphoblastic leukemia.

Nature genetics·2022
Same author

Acute lymphoblastic leukemia displays a distinct highly methylated genome.

Nature cancer·2022
Same author

Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.

Blood cancer discovery·2022
Same author

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators.

Blood cancer discovery·2021
Same journal

Temporal trajectories underlying adult neuronal diversity.

Current opinion in genetics & development·2026
Same journal

Transcription regulation of cell fate plasticity - from embryonic development to tissue regeneration.

Current opinion in genetics & development·2026
Same journal

Shared molecular and cellular programs during regeneration of glandular epithelia.

Current opinion in genetics & development·2026
Same journal

Lineage tracing in human cortical development.

Current opinion in genetics & development·2026
Same journal

Cis-regulatory strategies in developmental patterning.

Current opinion in genetics & development·2026
Same journal

GABAergic neuron fate specification and lineage allocation: from development to disorder.

Current opinion in genetics & development·2026
See all related articles

Murine models reveal that acute myeloid leukemia 1/core-binding factor beta-subunit (AML1/CBFbeta) fusion proteins are insufficient alone for leukemia development. These models aid in identifying cooperating mutations and testing novel therapies for core-binding factor acute myeloid leukemia.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Core-binding factor (CBF) leukemias are a common subtype of acute myeloid leukemia (AML).
  • Understanding the molecular pathology of CBF leukemias is crucial for developing effective treatments.
  • Murine models have recently been developed to study these leukemias.

Purpose of the Study:

  • To investigate the role of AML1/CBFbeta in hematopoietic stem cell self-renewal.
  • To determine the sufficiency of AML1/CBFbeta fusion proteins in inducing leukemia.
  • To establish the utility of murine models for identifying cooperating mutations and therapeutic targets.

Main Methods:

  • Development and analysis of murine models of core-binding factor leukemias.
  • Investigation of the self-renewal capacity of hematopoietic stem cells.

Related Experiment Videos

  • Assessment of the leukemogenic potential of AML1/CBFbeta fusion proteins.

    • Main Results:

    • Evidence suggests AML1/CBFbeta plays a critical role in controlling hematopoietic stem cell self-renewal.
    • Expression of AML1 or CBFbeta fusion proteins alone is insufficient to cause a full leukemic phenotype.
    • Murine models provide insights into the molecular mechanisms of CBF leukemias.

    Conclusions:

    • Murine models are valuable tools for studying core-binding factor leukemias.
    • These models can help define mutations cooperating with AML1/CBFbeta.
    • The models facilitate the assessment of novel therapies targeting altered pathways in CBF leukemias.